Puan Filzah shares about how she overcame cancer with the support of her family, offering hope and advice to others currently undergoing treatment. “Kalau saya boleh, maka semua orang boleh.” (If I can, so can everyone).
This animated explainer lays out the facts on biosimilars.
Our EU GMP-certified HAPI Plant is the oncology manufacturing facility which produces oncology medicines.
Our own Ms Noor Aida, General Manager at Duopharma Biotech, shares her story through early detection and healthy habits.
Located in Glenmarie, Shah Alam, Duopharma HAPI is the 1st Cancer Medicine Manufacturing Facility established in Malaysia.
For more information, see facilities.
According to the Malaysia National Cancer Registry Report2, cancer incidence has shown an overall increasing trend over the years, with a higher number of cases reported among females compared to males.
Breast cancer remains the most commonly diagnosed cancer, with 50.5% of cases identified at later stages (Stage 3 and 4).
Early detection & treatment saves lives.
Source: Malaysia National Cancer Registry Report2
Malaysia National Cancer Registry Report2
Malaysia National Cancer Registry Report2
and how do they compare to reference biologics in treating cancer?
Biosimilars are a growing treatment option for patients with conditions like cancer, diabetes, and other chronic diseases. They are highly similar to the original biologic in terms of safety and efficacy, while offering cost-savings. This helps more people access life-saving treatments while reducing overall healthcare costs.